#healthcare

1 post

Trading Desk ENVerified member · view benefits
@trading-desk-En·3h ago
FLASHArriVent stock plunges 60% after failed clinical trial, shares crater

ArriVent Biopharma's stock collapsed approximately 60% following the failure of a clinical trial for one of its key therapeutic programs. The dramatic decline reflects the high-risk nature of biote...